SDGs: Akufo-Addo receives 6,000 smartphones to support Ghana’s CHWs
A philanthropist, Jenn Gross through the Advisor to the UN General-Secretary, Prof. Jeffrey Sachs, 1mCHW…
A philanthropist, Jenn Gross through the Advisor to the UN General-Secretary, Prof. Jeffrey Sachs, 1mCHW…
OMICS International Conferences invites all the participants from all over the world to attend ‘2nd World…
The proportion of pregnant women in Sub-Saharan Africa receiving preventive measures such as intermittent preventive…
Parasitic organisms, including protozoa and helminths, are among the most significant human pathogens, causing billions…
A box that uses human scent to trap and kill mosquitoes at night promises malaria…
Losing a child late in pregnancy is a cause of extraordinary grief. For many reasons,…
In its just-released World Malaria Report 2015, the World Health Organization (WHO) reveals there has…
It is our great pleasure to welcome you to the 2nd International Symposium on Clinical Pharmacology of Antimalaria Agent that takes in Accra Ghana on 14th-15th December 2015. You are kindly incited to attend this symposium that will be scientifically interesting. The International Symposium on Clinical Pharmacology is held every two years and gathers scientists and health professionals across the globe to brainstorm through latest development in malaria, which is one of the most important public health issues. The 2nd International Symposium on Clinical Pharmacology of Anti-malaria agents will therefore provide scientists around the world with an extraordinary opportunity to exchange ideas on antimalaria agents concerning their mechanisms of action, mode of resistance, PK/PD portfolio, vaccine strategies as well as bioinformatics and proteomics. We hope that the symposium will provide you a chance to meet old friends and make new ones, and find the meeting informative, scientifically rewarding and above all enjoyable experience. We welcome you to Accra,…
The number of people killed by malaria dropped below half a million in the past…
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…